| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 265.6 | 259.7 | 219.2 |
| Other income | 11.6 | 3.3 | 4.1 |
| Total income | 277.2 | 263.0 | 223.3 |
| Profit before exceptional items & tax | 36.3 | 36.4 | 29.9 |
| Exceptional items | -3.1 | 0.0 | 0.0 |
| Profit before tax | 33.2 | 36.4 | 29.9 |
| Net profit | 30.4 | 32.2 | 24.9 |
| Operating margin | 12.0% | 13.8% | 13.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +22.10% |
|---|---|
| Net profit, quarter on quarter | -5.60% |
| Revenue, year on year | +21.20% |
BSE results filing, NSE: NEPHROPLUS. Figures extracted from the filing.
Nephrocare Health Services Ltd: key numbers
- Share price
- ₹643.00
- Market cap
- ₹6,452 Cr
- Revenue (annual)
- ₹998.8 Cr
- Net profit (annual)
- ₹76.84 Cr
- P/E (TTM)
- 75.8×Sector 53.1×
- Promoter holding
- 63.85%+0.00% QoQ
- FII holding
- 8.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephrocare Health Services Ltd
All →Nephrocare Health Services Credit Rating
India Ratings upgraded Nephrocare Health Services' long-term bank loan facilities to IND AA-/Stable. The agency also affirmed the company's short-term credit ratings.
Nephrocare Health Services Merger & Restructuring
Nephrocare Health Services Ltd announced the rationalisation and consolidation of its step-down subsidiaries in the Philippines. This internal reorganization streamlines the group's existing structure.
Nephrocare Health Services Merger & Restructuring Worth ₹10.25 Cr
Nephrocare's Philippines subsidiary acquired a dialysis center from Renal One Dialysis Corp for ≈₹10.25 Cr. The asset transfer expands the company's dialysis network.
- Value
- ₹10.25 Cr
- dialysis center acquired
- 1 dialysis centers
Nephrocare Health Services Acquisition Worth ₹10.25 Cr
Nephrocare's Philippines subsidiary is acquiring a dialysis center from Renal One Dialysis Corp. for a consideration of ₹10.25 crore.
- Value
- ₹10.25 Cr
Nephrocare Health Services Employee Stock Options
Nephrocare Health Services granted 4,01,362 employee stock options at an exercise price of ₹230 per share. These options are issued under the NephroPlus Employee Stock Option Scheme 2026.
Nephrocare Health Services Acquisition Worth ₹11.63 Cr
Nephroplus Health Services Kazakhstan LLP will acquire a 100% stake in 'Dialysis Center Almaty' LLP for approximately ₹11.64 Crore to expand its international dialysis network.
- Value
- ₹11.63 Cr